Advancing Dermatological Diagnostics with Molecular Precision
The Molecular Diagnostic Revolution for Dermatology
Bridging the Gap in Dermatology Diagnostics with Innovative Healthcare Solutions
Skin conditions like psoriasis and atopic dermatitis are on the rise, impacting millions of patients worldwide and challenging dermatologists to provide accurate diagnoses. In recent decades, treatments have evolved significantly, yet diagnostics have lagged behind, leaving a critical gap in precision care. Imagine offering your patients not just treatment, but confidence - the assurance of a precise diagnosis backed by cutting-edge molecular technology. Dermagnostix is revolutionizing dermatology with solutions designed to close this gap.
Our flagship product, PsorX-LabDisk, enables dermatopathology laboratories to provide molecular analysis with unmatched accuracy, transforming traditional workflows. Dermatologists can now request advanced molecular diagnostics from partner laboratories, enhancing their clinical decisions and elevating patient outcomes.
Join the next generation of dermatology professionals who are shaping a future of precision and innovation!
Coming soon: Our upcoming product PsorX 2.0 will enable dermatologists to perform differential diagnoses of psoriasis, eczema, and tinea directly at the Point-of-Care using minimal-invasive sampling methods.
Please contact us if you are interested in implementing the Dermagnostix system in your dermatology practice as soon as the test is available. If you are a dermatologists interested in research collaborations you are also very welcome to reach out to us.
Your Point-of-Care Molecular Diagnostic Solution
Your Benefits at a Glance

FAQs
At the moment, the Dermagnostix system is used by dermatopathology laboratories due to the necessity of FFPE samples. Please contact your pathology laboratory to request a mo-lecular analysis. A point-of-care test for dermatologists using non-invasive sampling methods is currently development.
Please contact us at info@dermagnostix.com to see if we can find a laboratory near your practice that we can put you in touch with.
No, the PsorX-LabDisk can only differentiate between psoriasis and eczema in general. The point-of-care follow-up product PsorX 2.0 will also be expanded to include the differentiation of tinea vs. eczema vs. psoriasis.
Molecular diagnostics offer clear, objective insights into skin conditions that are challenging to differentiate clinically, enabling faster and more accurate treatment decisions.
By delivering faster and more accurate diagnoses, we reduce uncertainty for patients and support personalized treatment plans.
Our portfolio currently includes tests for differentiating psoriasis and eczema, with pipeline products addressing other complex skin diseases such as tinea or mycosis fungoides.
Shaping the future of dermatology together!
